Measuring Immune Responses to Malaria Vaccine Antigens in Ghanaian Adults
Author Information
Author(s): Dodoo Daniel, Hollingdale Michael R, Anum Dorothy, Koram Kwadwo A, Gyan Ben, Akanmori Bartholomew D, Ocran Josephine, Adu-Amankwah Susan, Geneshan Harini, Abot Esteban, Legano Jennylyn, Banania Glenna, Sayo Renato, Brambilla Donald, Kumar Sanjai, Doolan Denise L, Rogers William O, Epstein Judith, Richie Thomas L, Sedegah Martha
Primary Institution: Noguchi Memorial Institute for Medical Research, University of Ghana
Hypothesis
To determine baseline antibody and T cell responses to candidate malaria vaccine antigens in Ghanaian adults.
Conclusion
All participants were positive for at least one malaria protein by ELISA, indicating significant biological variability in immune responses.
Supporting Evidence
- Positive antibody responses varied widely from 17%-100%, according to the antigen and statistical method.
- ELISA titres were higher in rural subjects.
- DR-restricted peptides showed stronger responses than Class I-restricted peptides.
- Results varied significantly between the two-week time-points for many participants.
Takeaway
Researchers wanted to see how people's immune systems reacted to malaria vaccine candidates, and they found that everyone had some response.
Methodology
Antibody titres were measured using ELISA and IFA, and T cell responses were assessed using ex vivo IFN-γ ELISpot assays.
Potential Biases
Potential bias due to the variability of immune responses and the small sample size.
Limitations
Results varied significantly between samples taken two weeks apart, indicating significant biological variability.
Participant Demographics
Healthy adults aged 18-55 from urban and rural communities in Ghana.
Statistical Information
P-Value
0.081
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website